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Background:  There is a critical scarcity of organs available for transplantation. to identify the trend of utilizing cardiac allografts from high-
risk donors (HRD) as defined by CDC guidelines, and estimate graft survival.
methods: We examined the UNOS database for patients (age ≥18) who received heart transplantation between 1994 and 2013 and have 
known donor graft status (high risk versus low risk). We excluded heart-lung transplantations.
results: Of 90,500 patients who received heart transplants, we identified 17,823 patients who met the inclusion criteria. Majority of 
recipients were Caucasian (69.3%), males (75.2%), with a mean age at transplant of 52.2 (+ 12.7) years. 1726 (9.7%) received cardiac 
allografts from HRDs. The utilization of HRDs has increased from 0 in 1994 to 215 in 2013. The 1-, 3-, and 5- year survival was 89%, 81% 
and 73% in HRD and 88%, 81%, and 75% in non-HRD (log rank p=0.44)
conclusion:  The utilization of cardiac allografts from high-risk donor has been increasing in the United States. Carefully selected high-risk 
cardiac allografts have equivalent survival to non-high risk allografts. 
